Lotus Pharmaceutical Co., Ltd. announced Election of Directors at 2023 Annual Shareholders' Meeting held on June 15, 2023. Title and name of the previous position holder: Dbirectors: Robert Wessman, Alvogen Emerging Markets Holdings Ltd. representative, Petar Vazharov, Alvogen Emerging Markets Holdings Ltd. representative, Arni Hardarson, Alvogen Emerging Markets Holdings Ltd. representative, Thor Kristjansson, Alvogen Emerging Markets Holdings Ltd. representative, Phannalin Mahawongtikul, Alvogen Emerging Markets Holdings Ltd., representative, Krisana Winitthumkul, Alvogen Emerging Markets Holdings Ltd. representative, Oranee Tangphao, Alvogen Emerging Markets Holdings Ltd. representative, Yves Hermes, Alvogen Emerging Markets Holdings Ltd. representative, Resume of the new position holder:Directors: Vilhelm Robert Wessman, Alvogen Emerging Markets Holdings Ltd. representative/Chairman at Lotus Pharmaceutical Co., Ltd. Petar Antonov Vazharov, Alvogen Emerging Markets Holdings Ltd. representative/Director & CEO at Lotus Pharmaceutical Co., Ltd. Arni Hardarson, Alvogen Emerging Markets Holdings Ltd. representative /Director at Lotus Pharmaceutical Co., Ltd. Thor Kristjansson, Alvogen Emerging Markets Holdings Ltd. representative/Director at Lotus Pharmaceutical Co., Ltd. Phannalin Mahawongtikul, Alvogen Emerging Markets Holdings Ltd. representative/Director at Lotus Pharmaceutical Co., Ltd. Krisana Winitthumkul, Alvogen Emerging Markets Holdings Ltd. representative/Director at Lotus Pharmaceutical Co., Ltd. Oranee Tangphao Daniels, Alvogen Emerging Markets Holdings Ltd. representative/Director at Lotus Pharmaceutical Co., Ltd. Yves Hermes, Alvogen Emerging Markets Holdings Ltd. representative /Director at Lotus Pharmaceutical Co., Ltd. Independent Directors: Hjorleifur Palsson,/Independent Director at Lotus Pharmaceutical Co., Ltd. Karl Alexius Tiger Karlsson, Executive Chairman at Newbury Pharmaceuticals AB Jennifer Wang, Independent Director at TXC Corporation. Effective date of the new appointment: June 15, 2023.